−1270KRW
−24.47 BKRW
81.83 BKRW
13.14 M
About CLS
Sector
Industry
Headquarters
Seoul
Website
Employees (FY)
77
Founded
2012
ISIN
KR7263700007
FIGI
BBG00K2160H5
Carelabs Co., Ltd. is a healthcare platform company that provides optimal software and content services. The company was founded on April 10, 2012 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 263700 is 3885 KRW — it has decreased by 2.14% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CLS stocks are traded under the ticker 263700.
263700 stock is 3.12% volatile and has beta coefficient of 1.48. Check out the list of the most volatile stocks — is CLS there?
CLS revenue for the last quarter amounts to 19.20 B KRW despite the estimated figure of 19.60 B KRW. In the next quarter revenue is expected to reach 20.40 B KRW.
Yes, you can track CLS financials in yearly and quarterly reports right on TradingView.
263700 stock has fallen by 0.26% compared to the previous week, the month change is a 19.31% fall, over the last year CLS has showed a 49.02% decrease.
263700 net income for the last quarter is −12.12 B KRW, while the quarter before that showed −6.71 B KRW of net income which accounts for −80.52% change. Track more CLS financial stats to get the full picture.
No, 263700 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 263700 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CLS stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 77.00 employees. See our rating of the largest employees — is CLS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CLS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CLS stock shows the sell signal. See more of CLS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CLS EBITDA is −7.27 B KRW, and current EBITDA margin is −8.89%. See more stats in CLS financial statements.